Roche sees testing time for COVID-19 diagnosis kit through 2021

Coronavirus 472 Health Care 291 Quote Watch 331 U.S. 4848

Medical supply chain security is becoming an issue heading into the northern hemisphere winter. Roche CEO, Severin Schwan, has stated “demand is by far oustripping supply” for diagnostic tests and that he expects “this to continue for quite some time in 2021, and it’s simply because we have huge back orders”. Shortages include components as well as complete kits in the U.S. Imports of test kits broadly were worth $387 million in September versus $422 million in the March to August period and were down by 8.8%. Imports of swabs were also below their peak while immunological reagents have ...

Copyright © 2021 Panjiva Supply Chain Intelligence, a product offering from S&P Global Market Intelligence Inc. All rights reserved.